PAR4 antagonist 7
PAR4 antagonist 7 (Compound 20f) is selective PAR4 antagonist (IC50: 1.72 nM). PAR4 antagonist 7 inhibits PAR4 agonist-induced platelet aggregation. PAR4 antagonist 7 has good metabolic stability. PAR4 antagonist 7 does not show a bleeding tendency in mice.
For research use only. We do not sell to patients.
- Formula: C28H20FN5O4S
- Molecular Weight:541.55
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
PAR4 antagonist 7 inhibits PAR4 agonist peptide (PAR4-AP) (75 μM)-induced washed platelet (WP) aggregation, with an IC50 of 15.32 nM[1].
PAR4 antagonist 7 inhibits PAR4-AP (75 μM) induced human platelet-rich plasma (PRP) levels, with an IC50 of 6.39 nM[1].
PAR4 antagonist 7 also inhibits AYPGKF-NH2 (75 μM) or Thrombin (0.1 U/mL) induced platelet aggregation of human PRP, and does not affect SFLLRN-NH2 (5 μM), Collagen (10 mg/mL), ADP (10 μM), or the U46619 (HY-108566) (3 μM) induced platelet aggregation[1].
PAR4 antagonist 7 shows excellent metabolic stability in human liver microsomes (T1/2 = 249.83 min[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Molecular Weight 541.55
-
Formula C28H20FN5O4S
-
SMILES
COC1=NC2=CC(C)=CC(C3=NC4=C(S3)C(C[C@@H](O5)COC(NC6=CC=CC(C#N)=C6)=O)=C5C(F)=C4)=C2C=N1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)